SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Apr 2015 07:00

RNS Number : 6595J
Victrex PLC
09 April 2015
 



 

 

 

 

 

9 April 2015

Victrex plc

Half year and pre-close trading update

'A good first half; well positioned for full year progress'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its half year and pre-close trading update for the six months ended 31 March 2015.

Overall, Victrex delivered a good first half performance. Group revenue of £130.3m was 9% ahead of the prior year (H1 2014: £119.9m), with Group sales volume of 2,028 tonnes 28% ahead of the prior year (H1 2014: 1,584 tonnes). The first half performance reflects a continuing positive contribution from Consumer Electronics and slightly lower sales in our Invibio medical business. Group gross margins saw improvement compared to the first half of 2014, reflecting better manufacturing efficiencies.

In Victrex Polymer Solutions (VPS), lower sales into oil and gas were offset by growth in our other markets. Commissioning of the first production stream on our third PEEK manufacturing plant is now complete and successfully started up on schedule. In Invibio, performance reflected the impact from industry consolidation in the US during Q1, as previously communicated, although we saw an improvement in Q2. Invibio revenue of £25.9m was 4% down on the prior year (H1 2014: £26.9m) and flat in constant currency, although our focus remains on continued improvement as we enter the second half.

The adverse currency impact seen by the Group during the first half will also continue into the second half. However, as previously communicated, we continue to expect that we will fully overcome the currency impact for the full year.

David Hummel, Chief Executive of Victrex, said: "Victrex delivered a good first half performance overall. Although we are mindful of the tougher comparatives for the second half and the continued caution in the oil and gas market, we remain well positioned for progress over the full year."

Victrex will report its interim results on Tuesday 19 May 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPCUPAGAR
Date   Source Headline
17th Jun 202111:29 amRNSDirector/PDMR Shareholding
16th Jun 20212:13 pmRNSAdditional Listing
2nd Jun 202111:10 amRNSDirector/PDMR Shareholding
1st Jun 20219:35 amRNSBlock listing Interim Review
28th May 20211:09 pmRNSTotal Voting Rights
18th May 20214:50 pmRNSDirector Declaration
18th May 202110:32 amRNSDirector/PDMR Shareholding
17th May 202110:56 amRNSDirector/PDMR Shareholding
13th May 202110:08 amRNSAdditional Listing
10th May 20217:00 amRNSVictrex plc Interim Results
30th Apr 20212:41 pmRNSTotal Voting Rights
19th Apr 20212:37 pmRNSDirector/PDMR Shareholding
16th Apr 202110:36 amRNSDirector Declaration
9th Apr 202111:00 amRNSAdditional Listing
31st Mar 20211:52 pmRNSTotal Voting Rights
17th Mar 20211:41 pmRNSDirector/PDMR Shareholding
1st Mar 202111:37 amRNSDirector/PDMR Shareholding
26th Feb 20211:47 pmRNSTotal Voting Rights
17th Feb 202110:32 amRNSDirector/PDMR Shareholding
12th Feb 20211:53 pmRNSResult of AGM
12th Feb 20217:00 amRNSAGM and Q1 Interim Management Statement
10th Feb 20212:37 pmRNSDirector/PDMR Shareholding
29th Jan 20212:33 pmRNSTotal Voting Rights
19th Jan 20213:50 pmRNSDirector/PDMR Shareholding
7th Jan 20212:06 pmRNSAnnual Report and Accounts
6th Jan 20212:34 pmRNSDirector/PDMR Shareholding
31st Dec 20209:00 amRNSTotal Voting Rights
17th Dec 20203:09 pmRNSDirector/PDMR Shareholding
15th Dec 202012:57 pmRNSDirector/PDMR Shareholding
11th Dec 20202:47 pmRNSDirector/PDMR Shareholding
9th Dec 20207:00 amRNSVictrex plc – Preliminary Results 2020
1st Dec 202010:59 amRNSBlock listing Interim Review
30th Nov 202011:24 amRNSTotal Voting Rights
17th Nov 20209:49 amRNSDirector/PDMR Shareholding
30th Oct 202011:40 amRNSTotal Voting Rights
19th Oct 202011:34 amRNSDirector/PDMR Shareholding
14th Oct 202012:17 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSVictrex plc Full Year Trading Statement
30th Sep 20209:30 amRNSTotal Voting Rights
29th Sep 20204:09 pmRNSHolding(s) in Company
17th Sep 202011:00 amRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSTotal Voting Rights
19th Aug 202011:01 amRNSDirector/PDMR Shareholding
31st Jul 202011:53 amRNSTotal Voting Rights
20th Jul 202010:45 amRNSDirector/PDMR Shareholding
17th Jul 20204:43 pmRNSDirector/PDMR Shareholding
8th Jul 20207:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202011:30 amRNSTotal Voting Rights
17th Jun 202011:44 amRNSDirector/PDMR Shareholding
15th Jun 20204:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.